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eletion of murine 
 
Smn
 
 exon 7, the most frequent
mutation found in spinal muscular atrophy, has
been directed to either both satellite cells, the muscle
progenitor cells and fused myotubes, or fused myotubes
only. When satellite cells were mutated, mutant mice develop
severe myopathic process, progressive motor paralysis, and
early death at 1 mo of age (severe mutant). Impaired muscle
regeneration of severe mutants correlated with defect of
myogenic precursor cells both in vitro and in vivo. In contrast,
when satellite cells remained intact, mutant mice develop
similar myopathic process but exhibit mild phenotype with
median survival of 8 mo and motor performance similar to
D
 
that of controls (mild mutant). High proportion of regener-
ating myoﬁbers expressing SMN was observed in mild
mutants compensating for progressive loss of mature myo-
ﬁbers within the ﬁrst 6 mo of age. Then, in spite of normal
contractile properties of myoﬁbers, mild mutants develop
reduction of muscle force and mass. Progressive decline of
muscle regeneration process was no more able to counter-
balance muscle degeneration leading to dramatic loss of myo-
ﬁbers. These data indicate that intact satellite cells remarkably
improve the survival and motor performance of mutant
mice suffering from chronic myopathy, and suggest a limited
potential of satellite cells to regenerate skeletal muscle.
 
Introduction
 
Mature muscle fibers of mammalian skeletal muscle (myo-
fibers) are multinucleate syncitia that arise from the fusion
of mononucleate precursors or myoblasts. Adult skeletal
muscle fibers display a remarkable capacity for regeneration
in response to muscle injury including progressive myopathies.
A population of precursor cells, termed satellite cells, located
between the sarcolemma and the basal lamina of the muscle
fibers, is responsible for this ability to regenerate (for review
see Seale et al., 2001). Such mononucleate cells, normally
quiescent, become activated after damage to proliferate and
differentiate, leading to the formation of multinucleate myo-
fibers either de novo or from preexisting muscle fibers. How-
ever, the therapeutic potential these cells might have for muscle
repair in inherited myopathies remains to be determined.
Spinal muscular atrophy (SMA)* is a frequent recessive
autosomal neuromuscular disorder characterized by degen-
eration of motor neurons associated with muscle paralysis
and atrophy. Mutations of the survival of motor neuron
gene (
 
SMN1
 
) are responsible for SMA (for review see
Frugier et al., 2002). SMN is a ubiquitously expressed protein
that has been involved in various processes including cyto-
plasmic assembly of snRNP into the spliceosome, pre-mRNA
splicing, transcription, and metabolism of ribosomal RNA
(for review see Paushkin et al., 2002). However, the molecular
pathway linking SMN defect to SMA phenotype remains to
be elucidated. Several strategies have been performed to
generate mouse models of SMA (for review see Frugier et al.,
2002). By using the Cre-LoxP system, deletion of murine
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Smn
 
 exon 7, the most frequent mutation found in SMA pa-
tients, has been directed to either neurons or skeletal muscle
(neuronal or muscular mutants; Frugier et al., 2000, 2002;
Cifuentes-Diaz et al., 2001, 2002).
To direct homozygous deletion of 
 
Smn
 
 to skeletal muscle,
Cre recombinase has been placed under the control of the hu-
man 
 
 
 
-skeletal actin gene promoter (
 
HSA-Cre
 
; Miniou et al.,
1999). Muscular mutant mice carry the 
 
HSA-Cre
 
 transgene
and a constitutive heterozygous deletion of 
 
Smn
 
 exon 7
(
 
Smn
 
 
 
7
 
), the other allele harboring two LoxP sequences flank-
ing exon 7 (
 
Smn
 
F7
 
). Such (
 
HSA-Cre
 
, 
 
Smn
 
F7/
 
 
 
7
 
) mice display a
severe phenotype characterized by necrosis of muscle fibers as-
sociated with destabilization of the sarcolemma components
(Cifuentes-Diaz et al., 2001). One striking observation was
the marked reduced life span of 
 
Smn
 
 muscular mutant mice
with median survival of 4 wk, whereas mice knockout for
genes encoding components of the dystrophin–glycoprotein
complex such as dystrophin (
 
mdx
 
 mouse) develop a milder
course of disease phenotype with an almost normal life span.
Therefore, sarcolemma destabilization was not sufficient to
explain muscle paralysis and death of muscular 
 
Smn
 
 mutant
mice. In those mice, the low proportion of myocytes with
central nuclei has suggested a weak regenerative process in re-
sponse to necrosis (Cifuentes-Diaz et al., 2001).
Here, we investigated the influence of satellite cell activity
in muscular mutant mice. As Cre-mediated deletion of 
 
Smn
 
exon 7 was found to occur in fused myotubes but not in sat-
ellite cells, deleterious effect of the constitutive heterozygous
deletion of 
 
Smn
 
 exon 7 (
 
Smn
 
 
 
7
 
) on muscle precursors was
suspected. Death of 25% myogenic-committed cells carrying
the (
 
Smn
 
 
 
7/
 
 
 
) genotype was observed in vitro. To determine
whether deleterious effect of 
 
Smn
 
 
 
7
 
 allele on muscle precur-
sor cells might be circumvented in vivo, mutant mice carry-
ing the (
 
HSA-Cre
 
, 
 
Smn
 
F7/F7
 
) instead of (
 
HSA-Cre
 
, 
 
Smn
 
F7/
 
 
 
7
 
)
genotype were generated. In (
 
HSA-Cre
 
, 
 
Smn
 
F7/F7
 
) mice, both
 
Smn
 
 alleles are intact in satellite cells, then become deleted in
multinucleate myotubes through Cre recombinase activity.
The phenotype of (
 
HSA-Cre
 
, 
 
Smn
 
F7/F7
 
) mutant mice was tre-
mendously attenuated in comparison with mice carrying the
(
 
HSA-Cre
 
, 
 
Smn
 
F7/
 
 
 
7
 
) genotype with an increase of median
survival from 1 to 8 mo. Similar muscular dystrophic changes
were observed yet in both types of mutants, but active muscle
regeneration process characterized (
 
HSA-Cre
 
, 
 
Smn
 
F7/F7
 
) mu-
tant mice. Here, we present a functional study of this myo-
pathic phenotype. The use of Cre recombinase transgenic
line directing 
 
Smn
 
 deletion in differentiated myotubes (but
not in satellite cells) allowed to generate a mouse model in
which mature muscle fibers are mutated, resulting in necro-
sis, whereas satellite cells remain intact, leading to efficient
muscle regeneration. For the first time, we demonstrate that
intact satellite cells markedly improved the survival and mo-
tor performance of mutant mice suffering from chronic mus-
cular necrosis through an active muscle regenerative process.
 
Results
 
Cre-mediated deletion of 
 
Smn
 
 occurs in fused 
myotubes, but not satellite cells
 
To determine the expression profile of the 
 
HSA-Cre
 
 recom-
binase transgene during myogenic differentiation, primary
 
myogenic cultures were prepared by enzymatic disaggrega-
tion of forelimb and hindlimb muscles from wild-type or
transgenic (
 
HSA-Cre
 
) newborn mice (Miniou et al., 1999).
Cells isolated from skeletal muscle tissues contain a mixture
of fibroblasts, myoblasts, adipocytes, and hematopoietic
cells. However, the muscle-derived cells can be enriched us-
ing the preplate technique based on the differential adher-
ence characteristic of primary muscle cells to dishes (Tassin
et al., 1991; Rando and Blau, 1994; Qu et al., 1998). After
two preplates, immunolabeling of desmin, the intermediate
filament protein specific to myogenic cells, was observed in
95% of cells 3 d after myoblast purification (unpublished
data). At that time, all desmin-positive cells were mononu-
cleated, and immunolabeling of the Cre recombinase was
negative in a total of 300 myogenic cells analyzed (Fig. 1).
At day 6, the ratio of differentiated myotubes containing
two or more nuclei to desmin-positive mononucleate cells
(i.e., fusion index) was determined by immunolabeling of
desmin and DAPI staining of nuclei. Fusion index was
49.5% in a total of 300 cells analyzed. Immunolabeling of
the Cre recombinase showed that 49.5% of cells were posi-
tive in a total of 300 cells analyzed, and all Cre-positive cells
were multinucleated (Fig. 1). No Trypan blue uptake into
myogenic committed cells was observed (unpublished data).
These data indicate that the 
 
HSA-Cre
 
 recombinase transgene
was expressed in multinucleate myotubes, but not in myo-
blasts, and was not toxic to myotubes.
To determine whether the Cre recombinase expression led
to deletion of exon 7 from 
 
Smn
 
F7
 
 allele, primary myogenic
cultures were performed from muscles dissected from (
 
HSA-
Cre
 
, 
 
Smn
 
F7/
 
 
 
) mice. PCR amplification analysis of DNA ex-
tracted from cells 0–8 d after myoblast purification was per-
formed using primers flanking the 
 
Smn
 
 deleted genomic
region (Fig. 2 A). No deletion of 
 
Smn
 
 exon 7 was observed
at day 0, indicating that satellite cells or myoblasts are not
Cre-mediated deleted in vivo
 
.
 
 
 
Smn
 
 exon 7 excision was ob-
served from day 6 in agreement with Cre recombinase ex-
pression (Fig. 2 A).
 
Heterozygous deletion of 
 
Smn
 
 exon 7 results in death 
of myogenic committed cells
 
To know whether constitutive heterozygous deletion of 
 
Smn
 
exon 7 might have any effect on myogenic proliferation or
differentiation, primary myogenic cultures were performed
from newborn skeletal muscles of mice carrying the (
 
Smn
 
 
 
/
 
 
 
)
or (
 
Smn
 
 
 
7/
 
 
 
) genotype. Immunoblot analysis was per-
formed by using an mAb specific to the NH
 
2
 
 terminus of
SMN, and revealed that SMN was highly expressed in myo-
genic committed cells including satellite cells or myoblasts
from day 0 (Fig. 2 B). Reduced amount of SMN was ob-
served in (
 
Smn
 
 
 
7/
 
 
 
) cells when compared with (
 
Smn
 
 
 
/
 
 
 
)
cells, indicating that 
 
Smn
 
 
 
7
 
 transcripts resulted in the ab-
sence of protein (Fig. 2 B). Proliferative capacity of myo-
blasts was determined by counting desmin-positive cells.
Starting from 10
 
4
 
 cells per plate at day 0, the number of
desmin-positive cells increased similarly in both (
 
Smn
 
F7/
 
 
 
)
and (
 
Smn
 
 
 
7/
 
 
 
) genotypes between day 3 and day 6 after
myoblast purification (Fig. 3 A). These data indicated that
proliferation of myogenic cells was not affected by heterozy-
gous deletion of 
 
Smn
 
 exon 7. However, death was observedT
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in 16 and 25% of (
 
Smn
 
 
 
7/
 
 
 
) cells in three independent ex-
periments as determined by Trypan blue dye uptake into
both myoblasts and fused myotubes at day 5 and day 6, re-
spectively (Fig. 3 B). No Trypan blue dye uptake into
(
 
Smn
 
 
 
/
 
 
 
) or (
 
Smn
 
F7/
 
 
 
) cells was observed (Fig. 3 B, and un-
published data). TUNEL staining was negative in (
 
Smn
 
 
 
7/
 
 
 
)
cells, suggesting that cell death occurred through a nonapop-
totic process (unpublished data).
To determine whether Cre-mediated deletion of 
 
Smn
 
 led
to similar deleterious effect on myogenic committed cells,
primary cultures were performed from transgenic mice car-
rying the (
 
HSA-Cre
 
, 
 
Smn
 
F7/
 
 
 
) genotype and compared with
those carrying the (
 
Smn
 
 
 
7/
 
 
 
) genotype. At day 5, death was
noticed in 16% of (
 
Smn
 
 
 
7/
 
 
 
) cells, but not in (
 
HSA-Cre
 
,
Smn
F7/ ) cells. At day 6, death was observed in 11 and 25%
of (HSA-Cre, Smn
F7/ ) and (Smn
 7/ ) cells, respectively (Fig.
3 A). The significantly higher proportion of dead cells in
(Smn
 7/ ) than in (HSA-Cre, Smn
F7/ , t test, P   0.0025 at
day 6) may be ascribed to either deleterious effect of Smn
 7
involving both myoblasts and fused myotubes, or to a selec-
tive advantage of negative Cre recombinase (HSA-Cre,
Smn
F7/ ) cells to grow. These data demonstrate that consti-
tutive heterozygous deletion of Smn (Smn
 7) led to a marked
defect of myogenic differentiation with death occurring in
25% of myogenic committed cells.
Marked improvement of Smn mutant phenotype is 
associated with active muscle regeneration process
To assess whether deleterious effect of Smn
 7 allele on mus-
cle precursor cells could be circumvented in vivo, mutant
mice carrying the (HSA-Cre, Smn
F7/F7) instead of (HSA-Cre,
Smn
F7/ 7) genotype were generated. In (HSA-Cre, Smn
F7/F7)
mice, both Smn alleles are intact in satellite cells, then Cre-
mediated deleted in multinucleate myotubes. Surprisingly,
although (HSA-Cre, Smn
F7/ 7) mice suffered from severe pa-
ralysis with a median survival of 33 d (n   39; Cifuentes-
Diaz et al., 2001), median survival of (HSA-Cre, Smn
F7/F7)
mice was 8 mo (n   28) representing a eightfold increase in
life span of mutant mice. A total of 24% of mice were still
alive after 12 mo of age. In addition, (HSA-Cre, Smn
F7/F7)
mutant mice exhibited motor performance similar to that of
control littermate (Smn
F7/ ) as determined by rotarod test.
From 1 to 6 mo of age, 100% of (HSA-Cre, Smn
F7/F7, n   6)
mutant mice were able to maintain their balance on the rod
rotating at either 5 or 10 rpm for 7 min. For these reasons,
(HSA-Cre, Smn
F7/F7) mutant mice were called “mild” mu-
Figure 1. Cre recombinase and desmin expression in primary 
myogenic cultures. Immunolabeling of the Cre recombinase (A and C) 
or desmin (B and D) were performed 3 (A–B ) or 6 d after myoblast 
purification from (HSA-Cre) transgenic mice (C–D ). Nuclei were 
stained with DAPI (A , B , C , and D ). Note the labeling of desmin 
(but not of Cre recombinase) in 3-d-old mononucleate myogenic 
cells, whereas in 6-d-old cells, Cre recombinase expression was 
observed in nuclei of fused myotubes. Bar, 40  m.
Figure 2. Genomic and protein analyses of Smn in primary 
myogenic cultures. (A) Cre-mediated deletion of Smn exon 7 occurs 
6 d after myoblast purification as determined by PCR amplification 
analysis of genomic DNA of (HSA-Cre, Smn
F7/ ) cells. DNA 
amplification of Cre recombinase transgene was used as internal 
positive control. (B) Immunoblot analysis of SMN in primary culture 
of skeletal muscles from control (Smn
 / ) and (Smn
 7/ ) mice. Proteins 
were extracted from cells at day 0 (lanes 1 and 2), 3 (lanes 3 and 4), 
and 6 (lanes 5 and 6) after myoblast purification. Note the reduced 
amount of SMN in Smn
 7/  cells (lanes 2, 4, and 6) when compared 
with Smn
 /  (lanes 1, 3, and 5) and actin expression.T
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tant compared with “severe” ones carrying the (HSA-Cre,
Smn
F7/ 7) genotype (Fig. 4).
To determine whether mild mutant mice developed mus-
cular changes, histological examination of skeletal muscles
including gastrocnemius, soleus, and quadriceps was per-
formed by using hematoxylin and eosin staining. No obvi-
ous histological changes of muscle fibers were observed in
1-mo-old mild mutant mice when compared with control,
except the presence of some rare necrotic fibers and myofi-
bers with central nuclei (Fig. 5). However, major changes
were seen from 2 to 12 mo of age, including variability in
fiber size, necrotic fibers, and regenerating myocytes with
central nuclei (Fig. 5). These data indicate that mild mu-
tant mice suffered from an active muscle necrosis regenera-
tion process. Dystrophin and utrophin immunostaining on
transverse muscle sections of 2-mo-old mild mutant mice
showed abnormal expression of both proteins in a pattern
similar to that previously observed in severe mutant mice
(Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200210117/DC1; Cifuentes-Diaz et al., 2001). There-
fore, in spite of the presence of severe myopathic process, the
(HSA-Cre,  Smn
F7/F7) mutant mice display a much milder
phenotype than that of (HSA-Cre, Smn
F7/ 7) mice.
Heterozygous deletion of Smn present in all cell types of
(HSA-Cre, Smn
F7/ 7), but not of (HSA-Cre, Smn
F7/F7) mu-
tant mice, might have a deleterious effect on the neighboring
cells such as motor neurons. To know whether a neurogenic
process, in addition to a myopathic one, was involved in the
pathogenesis of severe mutants, electromyographic studies
were performed in four 1-mo-old severe mutant (HSA-Cre,
Smn
F7/ 7) and control mice. Distal motor latencies and com-
pound muscle action potential (CMAP) amplitudes of gas-
trocnemius were recorded. Motor latencies of severe mutant
mice (986   172 ms) did not significantly differ from con-
trol mice (940   134 ms, P   0.68). CMAP amplitude can
be subdivided in two parts, and the amplitude of the nega-
tive and positive waves was determined (Fournier, 2000).
The amplitude of the negative wave of CMAP did not reveal
any difference between severe mutant and control mice
(35   6 and 42   7 mV, respectively; P   0.21). In con-
trast, the positive wave of CMAP was significantly decreased
in severe mutant mice (24   7 mV) as compared with that
of control mice of the same age (40   7 mV, P   0.02).
The reduced amplitude of the positive wave strongly sug-
gests that severe mutant mice suffer from a myopathic pro-
cess, and the absence of giant motor unit as determined by
the amplitude of the negative wave does not favor the hy-
pothesis of a neurogenic effect as being responsible for dif-
ference in the phenotypic severity of mutant mice.
To determine whether the mild phenotype of (HSA-Cre,
Smn
F7/F7) mutant mice might be caused by change in Cre re-
combinase transgene expression, Cre-mediated deletion of
Smn was evaluated in DNA extracted from skeletal muscle
of (HSA-Cre, Smn
F7/ ) mice coming from littermate of mild
or severe mutant mice. A similar ratio of Smn
F7/Smn
  was
observed in both genetic backgrounds, indicating no change
in Cre-mediated activity (Fig. S2). In addition, Cre-medi-
ated deletion of Smn exon 7 was found to be similar in 1- or
Figure 3. Kinetics of growth and cell death 
of myogenic committed cells from (Smn
F7/ ), 
(Smn
 7/ ), and (HSA-Cre, Smn
F7/ ) transgenic 
mice. (A) Starting from 10
4 cells per plate at day 0, 
number of living (curve) and dead cells (solid 
symbols) was evaluated from day 3 to day 6. Note 
that the kinetics of cell growth were similar in all 
genotypes analyzed. Dead cells were observed in 
both (Smn
 7/ ) and (HSA-Cre, Smn
F7/ ) cells with a 
significantly higher number in (Smn
 7/ ) than in 
(HSA-Cre, Smn
F7/ ). No cell death was observed in 
controls (Smn
F7/ ). (B) Trypan blue dye uptake into 
(Smn
 7/ ) myogenic cells including mononucleate 
(2, arrowhead) and multinucleate cells (3, arrow) 
6 d after myoblast purification. No Trypan blue 
uptake was observed in 6-d-old (Smn
F7/ ) cells (1). 
Bar, 40  m.T
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12-mo-old (HSA-Cre, Smn
F7/ ) mice coming from litter-
mate of mild mutants as determined by Smn
F7/Smn
  ratio
(Fig. S2). Consistently, similar Cre recombinase expression
was observed during life of mild mutant mice, as shown by
immunolabeling experiments of Cre recombinase on trans-
verse sections of gastrocnemius from 1- or 12-mo-old mild
mutant mice (Fig. S3). Both experiments demonstrate that
attenuation of the phenotype cannot be ascribed to reduced
Cre recombinase activity. These results were further sup-
ported by Western blot analysis of SMN in skeletal muscle
of mild and severe mutant mice. Similar reduction of SMN
protein expression was observed in 20-d-old mild and severe
mutant mice when compared with control littermate and ac-
tin expression (Fig. 6). Interestingly, marked increase of
SMN expression was observed in mild (but not in severe)
mutant mice from 35 d of age with a level similar than that
of control littermate of the same age and even higher at later
stage (Fig. 6). SMN protein may be provided by cells that
were not Cre-mediated deleted for Smn, and proliferating
myogenic committed cells expressing high level of SMN
might be regarded as strong candidates.
To test this hypothesis, muscle regeneration was evaluated
by determining the proportion of myofibers with central nu-
clei. Hematoxylin and eosin staining of transverse sections of
the entire soleus was performed from three control, mild, or
severe mutant mice. In mild mutant mice, the proportion of
myofibers with central nuclei was increasing from 0.7%
(mean of 6 out of 852, n   3) at 1 mo, to 31% at 2 mo
(mean of 256 out of 822, n   3), reaching the value of 44%
at 8 mo of age (mean of 278 out of 629, n   3; Fig. 7). In
contrast, proportion of myofibers with centrally placed nuclei
was  1% in both control (of 1- and 12-mo-old) and severe
mutant mice (1-mo-old; Fig. 7). The significant increased
proportion of regenerating myofibers from 1 to 2 mo (t test,
P   0.04) or to 8 mo of age (P   0.01; Fig. 7) indicates the
presence of an active muscle regeneration process in mild
mutant mice. Significant loss of mature myofibers was ob-
served in 2- and 8-mo-old mutant mice (566   113 SD and
351   162 SD, respectively; n   3 in each group) when
compared with 1-mo-old mild mutant mice (846   94 SD,
n   3, P   0.01; Fig. 7). However, the number of myofibers
with central nuclei was able to compensate for the loss of ma-
ture myofibers of mild mutant mice from 2 to 6 mo of age, as
total number of myofibers did not drop until 6 mo (Fig. 7).
To compare the muscle regeneration capacity of severe
mutants with that of mild mutant and control mice, myofi-
ber degeneration was provoked by intramuscular injection
of cardiotoxin in tibialis anterior of 3-wk-old control, se-
Figure 4. Phenotype of severe and mild mutant mice. Control littermate (A, Smn
F7/ ) and severe mutant mice (B, HSA-Cre, Smn
F7/ 7) at 1 mo 
of age. Note the posture of hindlimbs and dorsal kyphosis in severe mutant mice (B). (C and D) Mild mutant mice (HSA-Cre, Smn
F7/F7) of 5 (C) 
or 11 mo (D). Note the marked hypotonia associated with kyphosis and reduction of muscle mass in 11-mo-old (but not in 5-mo-old) mutants.T
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vere, and mild mutant mice. As determined by hematoxylin
and eosin staining on transverse sections, cardiotoxin in-
duced myofiber necrosis within 1 d after injection (unpub-
lished data). 8 d after cardiotoxin injection, muscle regener-
ation was quite similar in control and mild mutant mice,
but severe mutant mice exhibited impaired muscle regener-
ation. Severe mutant mice displayed significant reduction
in size of regenerating myofibers (Fig. 8). Indeed, myofibers
with central nuclei having size smaller than 900  m
2 repre-
sented 87% of regenerating myofibers in severe mutant
mice (278 out of 320) compared with 53% (176 out of
331,  
2, P   0.0001) in control or 46% in mild mutant
mice (148 out of 323,  
2, P   0.0001; Fig. 8). Early death
of severe mutant mice (median survival of 33 d) did not al-
low us to determine whether skeletal muscle architecture
was restored at a later stage.
To know whether the impairment of muscle regeneration
in severe (but not in mild) mutant mice might be caused by
defect of muscle progenitor cells in vivo, satellite cells were
examined in control, severe, and mild mutant mice. Immu-
nolabeling of Sca-1 and CD34 was performed on single
muscle fibers isolated from collagenase-digested flexor digi-
Figure 5. Hematoxylin and eosin staining of transverse sections of soleus from control, severe (HSA-Cre, Smn
F7/ 7, and mild mutant mice 
(HSA-Cre, Smn
F7/F7). At 1 mo of age, muscle histology of severe (B) or mild (C) mutants reveals necrotic fibers (arrow) and variation in fiber 
size (in severe mutant, only) when compared with control (A). At 2 mo of age (D), note the presence of necrotic fiber (arrow), numerous 
myofibers with central nuclei (arrowhead), and variation in fiber size in mild mutant mice. Marked morphological changes of skeletal muscle 
are observed in 6- (E) or 12-mo-old mild (F) mutant mice. Bar, 30  m.
Figure 6. Western blot analysis of SMN in skeletal muscles from 
control (Smn
F7/ ), severe (HSA-Cre, Smn
F7/ 7), and mild mutant 
mice (HSA-Cre, Smn
F7/F7). (A) At 20 d of age (left), the residual 
amount of SMN in mild (lane 3) or severe mice (lane 2) was similar. 
A marked increased amount of SMN was observed in 35-d-old mild 
(but not severe) mutant mice (right). (B and C) Note the marked 
decrease then increase of SMN expression in mild mutant mice from 
20 d to 8 mo of age. The high proportion of regenerating myofibers 
in which Cre-mediated deletion of Smn has not yet occurred 
combined with the high expression of SMN in myogenic committed 
cells (see Fig. 2 B) lead to a high level of SMN in mild mutant mice.T
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torum brevis (FDB) of 1-mo-old control, severe, and mild
mutant mice (Fig. 9). Satellite cells were shown to express
CD34, but not Sca-1, which further suggests that muscle-
derived stem cells and satellite cells are distinct cell popula-
tions as recently described (Asakura et al., 2002). A signifi-
cant reduction of CD34-expressing satellite cells per muscle
fiber was observed in severe mutant mice (18 out of 35 mus-
cle fibers, n   3 mice) when compared with mild mutant
mice (37 out of 36 muscle fibers, n   3 mice, P   0.02) or
control mice (38 out of 50, n   4 mice, P   0.02). The av-
erage fiber lengths of severe mutant mice (318  m   13
SEM, n   102 muscle fibers) did not significantly differ
from those of mild mutant mice (318  m   13 SEM, n  
30, P   0.98) or control mice (306  m   12 SEM, n   63,
P   0.45). These results indicate that differences in CD34-
expressing satellite cell number were not caused by differ-
ences in average fiber length, and reveal a significant reduc-
tion of subpopulation of satellite cells expressing CD34 in
severe (but not in mild) mutant mice.
Progressive motor defect of mild Smn mutant mice 
correlates with reduction of both regenerating and 
mature muscle fibers
Mild mutant mice did not display any detectable motor de-
fect within the first 6 mo of age, then developed progressive
motor weakness as determined by rotarod test. At 8 mo of
age, mutant mice (n   6) were no more able to maintain
their balance on the rod rotating at 5 rpm for 1 min,
whereas control mice succeeded the test for 7 min. Motor
defect was associated with the appearance of severe kyphosis
and atrophy of muscle masses (Fig. 4).
To determine whether the progressive decline in motor
performance of mild mutant mice was of myogenic or neu-
rogenic origin, electromyographic studies were performed in
Figure 7. Myofiber number of the entire soleus of severe and mild 
mutant mice. Open columns indicate the number of myofibers 
without central nuclei, whereas gray columns indicate those with 
central nuclei in mild mutant mice. At each age, three mild mutant 
mice were analyzed, except at 6 mo (one animal). Hatched column 
indicates the mean of myofiber number in three severe mutant mice 
at 1 mo of age. Horizontal dotted line indicates the mean of myofiber 
number in three control mice analyzed at 1 and 12 mo of age. 
Standard deviations of the mean number of myofibers with (left bar) 
or without central nuclei (right bar) are given. Note that regenerating 
myofibers with central nuclei are able to compensate for loss of 
mature myofibers in 2- to 6-mo-old mild mutant mice, then reduction 
of both regenerating and mature myofibers was observed, leading to 
massive loss of muscle fibers in 12-mo-old mild mutant mice.
Figure 8. Skeletal muscle regeneration after cardiotoxin injection 
in control, severe, and mild mutant mice. (A–C ) At day 5 (A–C), 
necrotic myofibers are associated with cellular infiltration and 
regenerative myofibers in control (A), severe (B), and mild mutant 
mice (C). At day 8 (A –C ), note the marked reduction in size 
of myofibers with central nuclei in severe mutants (B ) when 
compared with that of control (A ) or mild mutants (C ). Bar, 50  m. 
(D) Distribution of regenerating myofiber surface as determined by 
hematoxylin and eosin staining on transverse sections of tibialis 
anterior 8 d after cardiotoxin injection. Note the marked change 
in myofiber surface profile of severe mutant mice with respect to 
that of either control or mild mutants ( 
2, P   0.0001). No significant 
difference was observed between control and mild mutant mice 
( 
2, P   0.06).T
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three 11-mo-old control and mutant mice. Motor latencies
of CMAP of mild mutants (838   159 ms) did not signifi-
cantly differ from control mice (772   16 ms, P   0.3). In
mild mutant mice, the negative wave amplitude was not sta-
tistically different from control mice (34   5 and 32   6
mV, respectively; P   0.3). In contrast, positive wave ampli-
tude was significantly decreased in mutant mice (17 mV  
2.1 SD) as compared with that of controls of the same age
(27.4 mV   5 SD, t test, P   0.03). Furthermore, Cre-
mediated deletion of Smn was observed in skeletal muscles,
but not in other tissues including spinal cord or sciatic nerve
of 8-mo-old mutant mice (Fig. S4). These data indicated
that the progressive motor defect observed in mild mutant
mice was of myogenic origin only.
Mechanical properties of muscle were investigated on iso-
lated extensor digitorum longus (EDL), a fast-twitch mus-
cle, from 8-mo-old control and mild mutant mice. Marked
reduction of the muscle weight from 15.9   0.6 mg in con-
trols to 10.1   0.6 mg in mutants (P   0.001, n   5) was
first noted. The amplitude and kinetic characteristics of
short isometric tetanus showed a marked reduction in iso-
metric force (Table I). However, when isometric forces were
corrected for the muscle cross section (the “normalized”
force, mN.cm
 2), no difference between mutant and control
mice was observed, suggesting that reduction of isometric
force was a direct consequence of muscle mass reduction.
The rate of force development was markedly slowed down in
mutants and the difference remained, yet attenuated, when
this rate was expressed as a percentage of the tetanic force de-
veloped. Isolated muscles were also submitted to a series of
eccentric contractions where forced lengthening was im-
posed during maximal contraction. In five EDLs from mild
Smn mutants, an average force drop of 15% (  7, SD),
which remained within the range of drops observed in age-
matched controls, was observed (Table I; Deconinck et al.,
1997). The cytosolic concentration of Ca
2  at rest was
found to be quite similar in both mutant (24.5 nM   4.0,
SD, n   8) and control mice (28.9 nM   7.4, SD, n   4).
The passive influx of Ca
2  from the external medium was es-
timated by measuring the inward flux of Mn
2  ions (Merritt
et al., 1989). It amounted to 2.35%.min
 1 (  1.23, SD,
n   8) in fibers from mild mutants and 4.0%.min
 1 (  2.19,
SD, n   4) in controls. These values fall within the normal
ranges described previously (De Backer et al., 2002), and the
difference between control and mutant mice was not signifi-
cant (P   0.1). Altogether, these data indicate that mild
Smn mutant mice suffer from degenerative process of myofi-
bers that affects neither contractile properties nor Ca
2  ho-
Figure 9. Satellite cells on freshly isolated muscle fibers from control, severe, and mild mutant mice. Immunolabeling of CD34 was 
performed on isolated muscle fibers from FDB of control (A–A  ), severe (B–B  ), and mild mutant mice (C–C  ). Reduced number of CD34-
expressing satellite cells was observed in severe (but not mild) mutants. Satellite cell nuclei and myonuclei were stained with DAPI. Satellite 
cells do not express Sca-1 on isolated wild-type muscle fibers (D–D  ). Bar, 50  m.T
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meostasis. Consistently, mutant mice exhibited moderate el-
evation of serum creatine kinase activity (1,160 U/l   330
SD, n   18) when compared with control littermates of the
same age (476 U/l   220 SD, n   12, P   0.02). There-
fore, reduction of muscle force and mass was not caused by
defect of contractile properties of myofibers.
Hematoxylin and eosin staining of skeletal muscles of 8- or
12-mo-old mild mutant mice including gastrocnemius, so-
leus, and biceps brachii showed major reduction of muscle
size associated with myopathic changes including myofiber
necrosis, variation in size of myofibers with centrally placed
nuclei, and proliferative interstitial connective tissue (Fig. 5).
To determine whether atrophy of muscle mass was caused by
loss of muscle fibers, total myofiber number of the entire so-
leus was evaluated. Progressive reduction of myofiber num-
ber was observed in 8-mo-old mutant mice (629   226 SD,
n   3) and become dramatic at 12 mo (361   142 SD, n  
3) when compared with that of control mice of the same age
(811   122 SD, n   3, 55% reduction, t test, P   0.01;
Fig. 7). To know whether the loss of muscle fibers was due to
a progressive decline of muscle regeneration process in re-
sponse to chronic necrosis, the total number of regenerating
myofibers with central nuclei was evaluated in the same tis-
sue samples. A dramatic decreased number of myofibers with
central nuclei was observed in the entire soleus of 12-mo-old
mutant mice (78   56 SD, n   3) when compared with that
of 8-mo-old mutant mice (278   88 SD, 72% reduction,
P   0.03; Fig. 7). These results suggest that progressive defect
of muscle regeneration process associated with chronic skele-
tal muscle necrosis are responsible for loss of muscle fibers
leading to progressive motor defect of mild mutant mice.
Discussion
Studying SMA mouse models and skeletal muscle cells or bi-
opsies from SMA patients suggested that SMA phenotype
not only results from motoneuron impairment, but also
from constitutive skeletal muscle defects (Henderson et al.,
1987; Braun et al., 1995; Cifuentes-Diaz et al., 2001). Al-
though SMN was reported to be present in cytoplasmic dot-
like structures in both myoblasts in vitro and skeletal muscle
fibers of mice from postnatal day 1 to day 15 (Burlet et al.,
1998; Fan and Simard, 2002), its role in myogenic cell sur-
vival has never been explored. Primary myogenic cultures
from newborn mice revealed that SMN is highly expressed
in myoblasts and fused myotubes. A twofold decrease in
SMN expression results in death of 25% of myogenic
committed cells including myoblasts and fused myotubes
through a nonapoptotic process. These data indicate a
marked dosage effect of SMN on muscle precursor cell sur-
vival in vitro. The availability of a cellular model derived
from skeletal muscle affected in vivo in SMA should con-
tribute hereafter to a better knowledge of SMA pathogenesis
through investigation of molecular mechanisms underlying
muscle cell death.
Smn mutant mice were generated using the Cre-loxP sys-
tem that directs Smn exon 7 deletion not only in a given tis-
sue, but also at a given time depending on the Cre recombi-
nase transgene expression (Miniou et al., 1999; Frugier et
al., 2000; Cifuentes-Diaz et al., 2001, 2002). The Cre re-
combinase expression controlled by the HSA promoter was
observed in post-mitotic fused myotubes, but not in myo-
blasts both in vitro and in vivo. This system enabled us to
induce a deletion of Smn exon 7 restricted to fused myo-
tubes leading to necrosis process of myofibers while satellite
cells remain nondeleted. Regenerative capacity of intact sat-
ellite cells in response to damage of mature muscle fibers can
thus be evaluated. (HSA-Cre,  Smn
F7/F7) mutant mice, in
which the satellite cells are not deleted for Smn, exhibit mild
phenotype with median survival of 8 mo and motor perfor-
mance similar to that of controls within the first 6 mo of
age, despite severe myopathic process. In contrast, mutant
mice carrying the (HSA-Cre,  Smn
F7/ 7), in which satellite
cells are heterozygously deleted for Smn, develop acute ne-
crosis process of muscle fibers, progressive motor paralysis,
and early death at 1 mo of age (Cifuentes-Diaz et al., 2001).
Cre recombinase activity was similar in both types of mu-
tants. We cannot exclude the hypothesis that the heterozy-
gous deletion of Smn present in all cell types of severe (but
not of mild) mutant mice might have a deleterious effect
on the neighboring cells. However, neither morphological
changes of motor neurons nor skeletal muscle denervation
were observed in severe muscular mutant mice (Cifuentes-
Diaz et al., 2001 and the present paper). Our data strongly
suggest that the difference in phenotypic expression of mu-
tant mice was of myogenic origin only.
The major difference in muscle morphology between se-
vere and mild mutant mice consists of the appearance of an
active muscle regeneration process in mild (but not severe)
mutants. High proportion of regenerating myofibers is asso-
ciated with marked reexpression of SMN in skeletal muscle
of mild (but not severe) mutants, which likely arises from
proliferative nondeleted satellite cells. These results strongly
suggest that the partial rescue of the mild mutant mice
comes from an improved capacity of muscle regeneration
from intact satellite cells in response to similar damage of
mature muscle fibers. Consistently, impaired muscle repair
was observed in severe (but not mild) mutant mice in re-
sponse to muscle injury by cardiotoxin, growth of regenerat-
ing myofibers being markedly deficient. Impairment of mus-
cle regeneration in severe mutant mice can be ascribed to
Table I. Amplitude and kinetic characteristics of isometric tetanic 
contraction of EDL
Mechanical 
parameters
Mild Smn mutants
n   5, SEM
Controls
n   4, SEM
P
t test
Isometric force 
(mN)
182   19 323   5  0.001
Normalized 
isometric force 
(mN.cm
 2)
106   13 122   6 n.s.
Rate of force 
development 
(mN.ms
 1)
4.8   0.5 11.6   0.3  0.001
Rate of percentage 
of force 
development 
(% mN.ms
 1)
2.6   0.1 3.6   0.1  0.001
Time for half 
relaxation (ms)
65   6.6 53   7.5 n.s.
n.s., not significant.T
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defect of myogenic precursor survival in vitro and reduced
number of CD34-expressing satellite cells in vivo. Several re-
ports support the evidence that satellite cells are heteroge-
neous in nature with respect, for example, to the expression
of CD34, Myf5, and Sca-1 (Beauchamp et al., 2000; Qu-
Petersen et al., 2002). Characterizing subpopulation(s) of
cells and their derivatives dying in mutants should provide
insight into the nature of precursor cells committed to effi-
cient muscle regeneration.
Mild mutant mice exhibit progressive motor defect from 6
mo of age associated with severe reduction of muscle mass.
This correlates with a marked reduction of total muscle
force, as shown in vivo by the rotarod test or in vitro by
measuring the tetanic force of isolated muscles. However,
surprisingly, the contractile properties of the remaining
muscle fibers seem unaffected as they develop normal force
per unit cross section area and show no abnormal suscepti-
bility to high mechanical stress. The reduction of the rate of
force development is most likely the consequence of the
marked reduction of the fast myosin isoform transcripts, al-
though direct correlation remains to be determined (unpub-
lished data). Intracellular homeostasis of Ca
2  ions also
seems unaffected, and serum creatine kinase is moderately
elevated. These data clearly differentiate the mild Smn mu-
tant myopathy from a typical form of dystrophinopathy
such as found in mdx mice (for review see Gillis, 1999).
Marked reduction of muscle force correlates with a dra-
matic reduction of both regenerating and mature muscle fi-
bers. These data suggest a progressive decline in capacity of
myogenic committed cells to regenerate muscle fibers in re-
sponse to chronic necrosis in mild mutant mice. mdx mice
lacking dystrophin, a model for muscular dystrophy and re-
generation, develop neither motor defect of limbs nor reduc-
tion of muscle mass within the first year of life (Carnwath
and Shotton, 1987; Coulton et al., 1988). This apparent
paradox could be related to a progressive defect of skeletal
muscle regeneration in Smn (but not in mdx) mutant mice.
In 12-mo-old mild Smn mutant mice, dramatic decreased
number of both regenerating and mature muscle fibers was
observed in the entire soleus (mean of 72 out of a total of
361   142 SD, n   3). In contrast, a high number of regen-
erating myofibers was able to compensate for loss of mature
myofibers in mdx mice of the same age, leading to a total
number of myofibers similar to that of control mice (mean
of 555 out of a total of 1048   117 SD, n   2; unpublished
data). Although satellite cells are not deleted for Smn in mild
mutant mice, Cre-mediated deletion that occurs in fused
myotubes could lead to a progressive impairment of the
muscle regeneration process. Alternatively, proliferation po-
tential of satellite cells may be limited, as suggested by stud-
ies of human muscular dystrophies (for review see Cossu and
Mavilio, 2000). Because satellite cells carry the conditional
mutation, they undergo the same fate of degeneration as
soon as they differentiate into mature muscle fibers. One can
hypothesize that short and repeated cycles of myofiber de-
generation and regeneration in Smn (but not in mdx) mu-
tant mice could reveal a limited capacity of satellite cells to
regenerate skeletal muscle. Evaluating the amplitude and ki-
netics of degeneration process in both mdx and Smn mutant
mice should allow us to clarify this point.
The ability of myoblasts to become incorporated into
skeletal muscle during regeneration is exploited through
myoblast transplantation, a potential muscle cell–mediated
therapeutic approach for human progressive muscular dys-
trophies (for reviews see Cossu and Mavilio, 2000; Par-
tridge, 2000; Seale et al., 2001; Burton and Davies, 2002).
Transplantation of muscle precursor cells into mdx model
has shown that normal myoblasts can participate in muscle
regeneration, resulting in dystrophin expression in the host
muscle (Huard et al., 1994; Beauchamp et al., 1999; Qu-
Petersen et al., 2002). However, it remains difficult to deter-
mine whether this local rescue could lead to any functional
improvement, and the therapeutic potential that muscle
progenitor cells might have remains unclear. By using a
transgenic mouse line expressing the Cre recombinase in dif-
ferentiated skeletal muscle, Cohn et al. (2002) demonstrated
that maintenance of self-renewing potential of skeletal mus-
cle can prevent the development of severe dystrophic alter-
ations resulting from dystroglycan disruption. For the first
time, our data proved that intact satellite cells remarkably
improved the survival and motor performance of mutant
mice, despite the presence of severe myopathic process.
These results provide strong support to the view that use of
muscle progenitor cells should represent a rational and effi-
cient therapeutic strategy in muscular dystrophies. Smn mu-
tant mice should represent valuable tools for evaluating the
therapeutic benefits of cellular transplantation approaches.
Materials and methods
Mice
(HSA-Cre, Smn
F7/F7) or (HSA-Cre, Smn
F7/ 7) mutant mice were generated by
crossing homozygous (Smn
F7/F7) mice with mice carrying the Cre recombi-
nase transgene (HSA-Cre) and the (Smn
F7/ ) or (Smn
 7/ ) genotype, respec-
tively. (HSA-Cre,  Smn
F7/ ), (HSA-Cre,  Smn
 7/ ), (HSA-Cre,  Smn
 / ), and
(Smn
 7/ ) mice were maintained on C57BL/6J genetic background. (Smn
F7/ )
or (Smn
 / ) animals from littermate were used as controls. The genomic
organization of the Smn locus carrying either constitutive or Cre-mediated
deletion of Smn exon 7 is identical as described previously by Frugier et al.
(2000). Animals were genotyped by PCR amplification of DNA extracted
from tail biopsies (Miniou et al., 1999; Frugier et al., 2000). All animal pro-
cedures were performed in accordance with institutional guidelines
(agreement no. A91–228–2 and 3429).
Serum level of creatine kinase activity
Quantitative determination of creatine kinase activity of serum of control
(Smn
F7/ ) or mutant mice (HSA-Cre, Smn
F7/F7) was performed as described
previously (Cifuentes-Diaz et al., 2001).
Primary muscle cultures
Primary muscle cultures were prepared from newborn mice (3–5 d of age)
using a modified version of a previously described preplate technique
(Tassin et al., 1991; Rando and Blau, 1994). The muscle tissue was enzy-
matically dissociated in 0.25% trypsin without EDTA (Life Technologies) in
an equal volume of PBS at 37 C for 15 min. Cells were resuspended in
proliferation medium (PM) consisting of Dulbecco’s modified Eagle’s me-
dium supplemented with 10% horse serum (HS), 10% FBS, 1.25% chick
embryo extract, and 1% penicillin-streptomycin (GIBCO BRL). Myoblasts
were enriched by preplate technique on noncoated plastic dishes for 1 h.
The nonadherent cells were then collected and transferred to new dishes
for 4 h. The nonadherent cells were collected, counted, and plated (10
4
cells per dish) on 35-mm gelatin-coated dishes (1% gelatin; Sigma-
Aldrich). Cells were grown in PM at 37 C in 7.5% CO2. For Trypan blue
dye labeling, cells were trypsinized (0.25% trypsin with 2 mM EDTA; GIBCO
BRL), then an equal volume of Trypan blue dye was added (0.4% Trypan
blue stain; GIBCO BRL). Trypan blue uptake into cells was also performed
directly on dishes. Cells were washed in PBS, incubated in an equal vol-
ume of PBS and 0.4% Trypan blue stain for 1 min, and were then directlyT
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observed under a microscope (Axiophot; Carl Zeiss MicroImaging, Inc.).
For each analysis, independent experiments were performed from skeletal
muscles of at least three mice of each phenotype: wild type, (Smn
F7/ ),
(HSA-Cre), (Smn
 7/ ), or (HSA-Cre, Smn
F7/ ).
Single muscle fiber isolation
Single muscle fibers were isolated from the entire FDB muscle including ten-
dons of three 1-mo-old control, severe, and mild mutant mice according to
Rosenblatt et al. (1995). Muscles were digested with 0.2% collagenase type
IV (Sigma-Aldrich) for 30 min at 37 C under O2. The muscle was then trans-
ferred to 35-mm collagen-coated dishes containing 2 ml Krebs and triturated
using fire-polished pipettes to gently disaggregate the muscle fibers. Muscle
fibers were incubated for 2 h in a 37 C humidified incubator with 5% CO2 to
allow adhesion to the substratum. The average fiber lengths were evaluated
by using an imaging densitometer (model GS710; Bio-Rad Laboratories). For
immunolabeling of CD34 and Sca-1, isolated muscle fibers were fixed with
4% PFA in PBS for 5 min at RT, permeabilized with 0.03% Triton X-100 in
PBS, and were then incubated with 10% normal goat serum for 1 h. Antibod-
ies were incubated at 37 C for 1 h in concentrations as follows: FITC-coupled
rat anti–mouse CD34 mAb (1:100, RAM34; BD Biosciences) and biotin anti–
mouse Sca-1 antibody (1:200; BD Biosciences) revealed by Cy3-conjugated
streptavidin (1:500; US Biological). The nuclei were stained with DAPI.
Cardiotoxin-induced muscle injury
Mice were deeply anesthetized with 100 mg/kg ketamine and 10 mg/kg
xylazine. Cardiotoxin (50  l of 10  M diluted in PBS; Latoxan) was in-
jected in tibialis anterior of three 3-wk-old control, severe, and mild mu-
tant mice (Garry et al., 1997). The tibialis anterior muscles were harvested
1, 5, and 8 d after the cardiotoxin injection and frozen in cold isopentane.
10- m transverse sections performed each 100  m were stained with he-
matoxylin and eosin. Surface of myofibers with central nuclei was evalu-
ated on serial transverse sections 8 d after cardiotoxin injection using
Q-Fluoro software (Leica). 53% of myofibers with central nuclei had size
 900   m
2 in control mice. The proportion of regenerating myofibers
 900  m
2 was then determined in severe and mild mutant mice and com-
pared with that of control mice by using a  
2 test for statistical analysis.
Histological and immunolabeling experiments of muscle tissues 
and cultures
10- m transverse sections of isopentane-frozen skeletal muscles including
gastrocnemius, soleus, quadriceps, and biceps brachii were stained with
hematoxylin and eosin. To evaluate the total number of muscle fibers with
or without central nuclei, the entire soleus was dissected and serial sec-
tions were performed every 400  m. Counting was made after hematoxy-
lin and eosin staining, and the highest number of myofibers per muscle
section was retained for statistical analysis. Three (HSA-Cre, Smn
F7/F7) mu-
tant mice of 1, 2, 8, and 12 mo of age, one of 6 mo, and three 1-mo-
old (HSA-Cre, Smn
F7/ 7) mutant mice were included in this work. Three
(Smn
F7/ ) mice of 1 and 12 mo of age were used as controls.
Double immunostaining of dystrophin and utrophin was performed as
described previously (Cifuentes-Diaz et al., 2001). For desmin immunola-
beling of culture muscle cells, cells were fixed in cold methanol for 1 min
at 4 C, incubated in 10% horse serum for 1 h at RT, and were then incu-
bated with desmin mAb (1:500, DE-B5; CHEMICON International). After
washing, cells were incubated with rhodamine-coupled secondary anti-
body (1:5,000; Jackson ImmunoResearch Laboratories), then mounted in
Vectashield
® with DAPI (Vector Laboratories). For Cre recombinase immu-
nolabeling, the same procedure was applied by using Cre recombinase
mAb (1:200, 2D8; Euromedex). Preparations were observed under a fluo-
rescence microscope (Axiophot; Carl Zeiss MicroImaging, Inc.).
Determination of Cre recombinase activity by DNA analysis
Tissues were incubated overnight at 55 C in 0.1 M Tris-HCl, 5 mM EDTA,
pH 8.0 0.2% SDS, and 0.2 M NaCl supplemented with 0.2 mg/ml of pro-
teinase K. After phenol/chloroform extraction, genomic DNA was resus-
pended in Tris EDTA 10:1 buffer. PCR amplification of Smn exon 4 using
primers flanking this exon was used as internal positive control (Frugier et
al., 2000). Detection of the Smn
 7 allele was performed by PCR amplifica-
tion using primers pHR5 and GS8 (Frugier et al., 2000). The wild-type and
Smn
F7 alleles were simultaneously amplified by PCR using primers
ex7sou1 and GS8 (Frugier et al., 2000). The efficiency of excision was esti-
mated by comparing the intensity of the band amplified from the Smn 
F7 al-
lele with that from the wild-type allele (Smn
 ). Ratio of Smn
F7/Smn
  was
evaluated by scanning of PCR amplification products with an imaging den-
sitometer (model GS710; Bio-Rad Laboratories) and analyzed with Quan-
tity One software (Bio-Rad Laboratories).
Immunoblotting experiments
Frozen skeletal muscle (quadriceps or gastrocnemius) of three control and
mutant mice were rapidly frozen and crushed in liquid nitrogen using a mor-
tar and pestle. The pulverized muscle samples were transferred into 5 vol of
a buffer containing 25 mM sodium phosphate, pH 7.2, 5 mM EDTA, and 1%
SDS supplemented with protease inhibitor cocktail (Sigma-Aldrich), and
boiled for 5 min. Protein sample (25–50  g) was mixed with an equal vol-
ume of 2  Laemmli buffer, electrophoresed, then transferred. For SMN and
actin immunodetection, anti-SMN and anti-actin mAb were used (1:5,000,
Transduction laboratories; 1:10,000, CHEMICON International, respec-
tively). Frozen muscle cell pellets were lysed into the same extraction buffer.
Rotarod test
Testing began at 15 d of age and animals were studied every 4 d, then
once a week after 1 mo of age. Rotarod was performed as described previ-
ously (Cifuentes-Diaz et al., 2002).
Electromyographic studies
After deep anaesthetization, CMAP of gastrocnemius of three 11-mo-old
mild mutants, four 1-mo-old severe mutants, and three control mice of the
same ages were elicited after supramaximal stimulation of the sciatic nerve
using an electromyographic apparatus (Keypoint 2; Medtronic). Latency
and peak-to-peak amplitude were recorded and analyzed.
Muscle mechanics
Animals were deeply anaesthetized with ketamine and xylazine in order to
preserve muscle perfusion during dissection of the EDL and the FDB. The
Animal Ethics Committee of the Catholic University of Louvain (Brussels,
Belgium) has approved this protocol. Electrical stimuli and isometric force
of isolated EDL were sampled through an RTI-8 15 AD converter and digi-
tized as described previously (Deconinck et al., 1997). A series of twitches
and 0.3 s tetani were applied, in order to determine the length at which
isometric tetanus force was maximal. After the recording of representative
isometric twitch and tetanus, a 5-min rest was imposed, followed by the
eccentric contraction protocol (Deconinck et al., 1997). This consisted of a
series of 6 isometric tetani of 0.35 s duration in which a 7% lengthening of
the muscle was applied, at a rate of 1 fiber length.s
 1, when maximal force
had been developed, i.e., after 0.15 s. Tetani were separated by 5 min rest
during which the initial muscle length was restored. The isometric force
drop (in %) is the decrease of the isometric force from the first to the sixth
eccentric contraction.
Cytosolic Ca
2  concentration and Ca
2  influx 
in single FDB fibers
The experimental protocol has been previously described in detail (De
Backer et al., 2002). In short, FDB muscles were submitted to collagenase
digestion, then single fibers were loaded with the cell-permeant Ca
2  indi-
cator Fura-PE3-AM. Cytosolic [Ca
2 ] was estimated by recording the inten-
sity of fluorescence (Grynkiewicz et al., 1985; De Backer et al., 2002).
Then, fibers were changed to a Ca
2 -free Krebs solution containing 500
 M MnCl2. Influx of Mn
2  into fibers loaded with Fura-PE3 quenches the
fluorescence of the dye and the quenching rate reflects the influx rate of
Ca
2  ions (Merritt et al., 1989). Results were expressed as percent decrease
of Fura-PE3 fluorescence per minute (in short: %.min
 1).
Online supplemental material
Fig. S1 shows the immunostaining of sarcolemma components (dystrophin
and utrophin) in mild mutant mice. Fig. S2 shows the characterization of
Cre recombinase activity in mild and severe genetic backgrounds. Fig. S3
shows the immunolabeling of Cre recombinase on tissue sections of 1- and
12-mo-old mild mutant mice. Fig. S4 shows that Cre-mediated deletion of
Smn exon 7 is restricted to skeletal muscle in mild mutant mice. Online
supplemental material available at http://www.jcb.org/cgi/content/full/
jcb.200210117/DC1.
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